Meanwhile, Semaglutide GLP-1 (Ozempic, Wegovy) has shown promising results in terms of weight loss, despite its primary use for treating type 2 diabetes
According to KFF polling from May 2024, 6% of all adults report that they currently are taking a GLP-1 drug, and 12% report that theyve ever taken a GLP-1 drug
Therefore, the fact remains that the benefits of L-carnitine (as well as those of other supplements), can be indirect and take longer to be extremely visible, for example weeks, unlike supplements that can directly affect sports performance (such as creatine and caffeine), but certainly not less for the systemic effects on the well-being and health of the person who uses it
Retrieved from Dailey, M
Des millions de personnes dans le monde dcouvrent les traitements avec des GLP-1
171 However, their clinical translation has been modest, underscoring the complexity of transporter-targeted therapy